 | • レポートコード：MRC2012A6372 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、神経学的バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。神経学的バイオマーカーの種類別市場規模（プロテオミクス、ゲノミクス、イメージング、バイオインフォマティクス、その他）、用途別市場規模（診断、創薬、個別化医療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、QIAGEN、Abbott、Merck、Bio-Rad Laboratories、Quest Diagnostics、Cisbio Bioassays、Illumina、Roche、Myriad RBM、Proteome Sciences、Athena Diagnostics、Genewiz、Aepodia、BGI、Wuxi APP、 ・地域別グローバル市場分析 2015年-2020年 ・神経学的バイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・神経学的バイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・神経学的バイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・神経学的バイオマーカーの南米市場（ブラジル、アルゼンチン） ・神経学的バイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プロテオミクス、ゲノミクス、イメージング、バイオインフォマティクス、その他 ・用途別分析：診断、創薬、個別化医療、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Neurological Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Neurological Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 8342.7 million by 2025, from USD 5869.8 million in 2019.
Market segmentation
Neurological Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neurological Biomarkers market has been segmented into
Proteomics
Genomics
Imaging
Bioinformatics
Others
By Application, Neurological Biomarkers has been segmented into:
Diagnostics
Drug Discovery
Personalized Medicine
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neurological Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Neurological Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neurological Biomarkers market.
The report offers in-depth assessment of the growth and other aspects of the Neurological Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neurological Biomarkers Market Share Analysis
Neurological Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neurological Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neurological Biomarkers sales, revenue and market share for each player covered in this report.
The major players covered in Neurological Biomarkers are:
Thermo Fisher Scientific
QIAGEN
Abbott
Merck
Bio-Rad Laboratories
Quest Diagnostics
Cisbio Bioassays
Illumina
Roche
Myriad RBM
Proteome Sciences
Athena Diagnostics
Genewiz
Aepodia
BGI
Wuxi APP
Among other players domestic and global, Neurological Biomarkers market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurological Biomarkers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurological Biomarkers, with price, sales, revenue and global market share of Neurological Biomarkers in 2018 and 2019.
Chapter 3, the Neurological Biomarkers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Biomarkers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neurological Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neurological Biomarkers sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neurological Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neurological Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Overview of Global Neurological Biomarkers Market
1.4.1 Global Neurological Biomarkers Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 QIAGEN
2.2.1 QIAGEN Details
2.2.2 QIAGEN Major Business
2.2.3 QIAGEN SWOT Analysis
2.2.4 QIAGEN Product and Services
2.2.5 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad Laboratories
2.5.1 Bio-Rad Laboratories Details
2.5.2 Bio-Rad Laboratories Major Business
2.5.3 Bio-Rad Laboratories SWOT Analysis
2.5.4 Bio-Rad Laboratories Product and Services
2.5.5 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Quest Diagnostics
2.6.1 Quest Diagnostics Details
2.6.2 Quest Diagnostics Major Business
2.6.3 Quest Diagnostics Product and Services
2.6.4 Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cisbio Bioassays
2.7.1 Cisbio Bioassays Details
2.7.2 Cisbio Bioassays Major Business
2.7.3 Cisbio Bioassays Product and Services
2.7.4 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Product and Services
2.8.4 Illumina Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Product and Services
2.9.4 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Myriad RBM
2.10.1 Myriad RBM Details
2.10.2 Myriad RBM Major Business
2.10.3 Myriad RBM Product and Services
2.10.4 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Proteome Sciences
2.11.1 Proteome Sciences Details
2.11.2 Proteome Sciences Major Business
2.11.3 Proteome Sciences Product and Services
2.11.4 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Athena Diagnostics
2.12.1 Athena Diagnostics Details
2.12.2 Athena Diagnostics Major Business
2.12.3 Athena Diagnostics Product and Services
2.12.4 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Genewiz
2.13.1 Genewiz Details
2.13.2 Genewiz Major Business
2.13.3 Genewiz Product and Services
2.13.4 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Aepodia
2.14.1 Aepodia Details
2.14.2 Aepodia Major Business
2.14.3 Aepodia Product and Services
2.14.4 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 BGI
2.15.1 BGI Details
2.15.2 BGI Major Business
2.15.3 BGI Product and Services
2.15.4 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Wuxi APP
2.16.1 Wuxi APP Details
2.16.2 Wuxi APP Major Business
2.16.3 Wuxi APP Product and Services
2.16.4 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neurological Biomarkers Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neurological Biomarkers Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neurological Biomarkers Manufacturer Market Share in 2019
3.3.2 Top 6 Neurological Biomarkers Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Regions
4.1.1 Global Neurological Biomarkers Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neurological Biomarkers Revenue and Market Share by Regions (2015-2020)
4.2 North America Neurological Biomarkers Sales and Growth Rate (2015-2020)
4.3 Europe Neurological Biomarkers Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neurological Biomarkers Sales and Growth Rate (2015-2020)
4.5 South America Neurological Biomarkers Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neurological Biomarkers Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neurological Biomarkers Sales, Revenue and Market Share by Country
5.1.1 North America Neurological Biomarkers Sales and Market Share by Country (2015-2020)
5.1.2 North America Neurological Biomarkers Revenue and Market Share by Country (2015-2020)
5.2 United States Neurological Biomarkers Sales and Growth Rate (2015-2020)
5.3 Canada Neurological Biomarkers Sales and Growth Rate (2015-2020)
5.4 Mexico Neurological Biomarkers Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neurological Biomarkers Sales, Revenue and Market Share by Country
6.1.1 Europe Neurological Biomarkers Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neurological Biomarkers Revenue and Market Share by Country (2015-2020)
6.2 Germany Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.3 UK Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.4 France Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.5 Russia Neurological Biomarkers Sales and Growth Rate (2015-2020)
6.6 Italy Neurological Biomarkers Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neurological Biomarkers Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neurological Biomarkers Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neurological Biomarkers Revenue and Market Share by Regions (2015-2020)
7.2 China Neurological Biomarkers Sales and Growth Rate (2015-2020)
7.3 Japan Neurological Biomarkers Sales and Growth Rate (2015-2020)
7.4 Korea Neurological Biomarkers Sales and Growth Rate (2015-2020)
7.5 India Neurological Biomarkers Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neurological Biomarkers Sales and Growth Rate (2015-2020)
7.7 Australia Neurological Biomarkers Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neurological Biomarkers Sales, Revenue and Market Share by Country
8.1.1 South America Neurological Biomarkers Sales and Market Share by Country (2015-2020)
8.1.2 South America Neurological Biomarkers Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neurological Biomarkers Sales and Growth Rate (2015-2020)
8.3 Argentina Neurological Biomarkers Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neurological Biomarkers Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neurological Biomarkers Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neurological Biomarkers Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.3 Turkey Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.4 Egypt Neurological Biomarkers Sales and Growth Rate (2015-2020)
9.5 South Africa Neurological Biomarkers Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neurological Biomarkers Sales and Market Share by Type (2015-2020)
10.2 Global Neurological Biomarkers Revenue and Market Share by Type (2015-2020)
10.3 Global Neurological Biomarkers Price by Type (2015-2020)
11 Global Neurological Biomarkers Market Segment by Application
11.1 Global Neurological Biomarkers Sales Market Share by Application (2015-2020)
11.2 Global Neurological Biomarkers Revenue Market Share by Application (2015-2020)
11.3 Global Neurological Biomarkers Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neurological Biomarkers Sales, Revenue and Growth Rate (2021-2025)
12.2 Neurological Biomarkers Market Forecast by Regions (2021-2025)
12.2.1 North America Neurological Biomarkers Market Forecast (2021-2025)
12.2.2 Europe Neurological Biomarkers Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neurological Biomarkers Market Forecast (2021-2025)
12.2.4 South America Neurological Biomarkers Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neurological Biomarkers Market Forecast (2021-2025)
12.3 Neurological Biomarkers Market Forecast by Type (2021-2025)
12.3.1 Global Neurological Biomarkers Sales Forecast by Type (2021-2025)
12.3.2 Global Neurological Biomarkers Market Share Forecast by Type (2021-2025)
12.4 Neurological Biomarkers Market Forecast by Application (2021-2025)
12.4.1 Global Neurological Biomarkers Sales Forecast by Application (2021-2025)
12.4.2 Global Neurological Biomarkers Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neurological Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neurological Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neurological Biomarkers Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Neurological Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Thermo Fisher Scientific Neurological Biomarkers Major Business
Table 10. Thermo Fisher Scientific Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 11. Thermo Fisher Scientific SWOT Analysis
Table 12. Thermo Fisher Scientific Neurological Biomarkers Product and Services
Table 13. Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 15. QIAGEN Neurological Biomarkers Major Business
Table 16. QIAGEN Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 17. QIAGEN SWOT Analysis
Table 18. QIAGEN Neurological Biomarkers Product and Services
Table 19. QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Abbott Basic Information, Manufacturing Base and Competitors
Table 21. Abbott Neurological Biomarkers Major Business
Table 22. Abbott Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 23. Abbott SWOT Analysis
Table 24. Abbott Neurological Biomarkers Product and Services
Table 25. Abbott Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Merck Basic Information, Manufacturing Base and Competitors
Table 27. Merck Neurological Biomarkers Major Business
Table 28. Merck Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 29. Merck SWOT Analysis
Table 30. Merck Neurological Biomarkers Product and Services
Table 31. Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 33. Bio-Rad Laboratories Neurological Biomarkers Major Business
Table 34. Bio-Rad Laboratories Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 35. Bio-Rad Laboratories SWOT Analysis
Table 36. Bio-Rad Laboratories Neurological Biomarkers Product and Services
Table 37. Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 39. Quest Diagnostics Neurological Biomarkers Major Business
Table 40. Quest Diagnostics Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 41. Quest Diagnostics SWOT Analysis
Table 42. Quest Diagnostics Neurological Biomarkers Product and Services
Table 43. Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Cisbio Bioassays Basic Information, Manufacturing Base and Competitors
Table 45. Cisbio Bioassays Neurological Biomarkers Major Business
Table 46. Cisbio Bioassays Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 47. Cisbio Bioassays SWOT Analysis
Table 48. Cisbio Bioassays Neurological Biomarkers Product and Services
Table 49. Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Illumina Basic Information, Manufacturing Base and Competitors
Table 51. Illumina Neurological Biomarkers Major Business
Table 52. Illumina Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 53. Illumina SWOT Analysis
Table 54. Illumina Neurological Biomarkers Product and Services
Table 55. Illumina Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Roche Basic Information, Manufacturing Base and Competitors
Table 57. Roche Neurological Biomarkers Major Business
Table 58. Roche Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 59. Roche SWOT Analysis
Table 60. Roche Neurological Biomarkers Product and Services
Table 61. Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Myriad RBM Basic Information, Manufacturing Base and Competitors
Table 63. Myriad RBM Neurological Biomarkers Major Business
Table 64. Myriad RBM Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 65. Myriad RBM SWOT Analysis
Table 66. Myriad RBM Neurological Biomarkers Product and Services
Table 67. Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table 69. Proteome Sciences Neurological Biomarkers Major Business
Table 70. Proteome Sciences Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 71. Proteome Sciences SWOT Analysis
Table 72. Proteome Sciences Neurological Biomarkers Product and Services
Table 73. Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table 75. Athena Diagnostics Neurological Biomarkers Major Business
Table 76. Athena Diagnostics Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 77. Athena Diagnostics SWOT Analysis
Table 78. Athena Diagnostics Neurological Biomarkers Product and Services
Table 79. Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Genewiz Basic Information, Manufacturing Base and Competitors
Table 81. Genewiz Neurological Biomarkers Major Business
Table 82. Genewiz Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 83. Genewiz SWOT Analysis
Table 84. Genewiz Neurological Biomarkers Product and Services
Table 85. Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Aepodia Basic Information, Manufacturing Base and Competitors
Table 87. Aepodia Neurological Biomarkers Major Business
Table 88. Aepodia Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 89. Aepodia SWOT Analysis
Table 90. Aepodia Neurological Biomarkers Product and Services
Table 91. Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. BGI Basic Information, Manufacturing Base and Competitors
Table 93. BGI Neurological Biomarkers Major Business
Table 94. BGI Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 95. BGI SWOT Analysis
Table 96. BGI Neurological Biomarkers Product and Services
Table 97. BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Wuxi APP Basic Information, Manufacturing Base and Competitors
Table 99. Wuxi APP Neurological Biomarkers Major Business
Table 100. Wuxi APP Neurological Biomarkers Total Revenue (USD Million) (2018-2019)
Table 101. Wuxi APP SWOT Analysis
Table 102. Wuxi APP Neurological Biomarkers Product and Services
Table 103. Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Global Neurological Biomarkers Sales by Manufacturer (2018-2019) (K Units)
Table 105. Global Neurological Biomarkers Revenue by Manufacturer (2018-2019) (USD Million)
Table 106. Global Neurological Biomarkers Sales by Regions (2015-2020) (K Units)
Table 107. Global Neurological Biomarkers Sales Market Share by Regions (2015-2020)
Table 108. Global Neurological Biomarkers Revenue by Regions (2015-2020) (USD Million)
Table 109. North America Neurological Biomarkers Sales by Countries (2015-2020) (K Units)
Table 110. North America Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table 111. North America Neurological Biomarkers Revenue by Countries (2015-2020) (USD Million)
Table 112. North America Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Table 113. Europe Neurological Biomarkers Sales by Countries (2015-2020) (K Units)
Table 114. Europe Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table 115. Europe Neurological Biomarkers Revenue by Countries (2015-2020) (USD Million)
Table 116. Asia-Pacific Neurological Biomarkers Sales by Regions (2015-2020) (K Units)
Table 117. Asia-Pacific Neurological Biomarkers Sales Market Share by Regions (2015-2020)
Table 118. Asia-Pacific Neurological Biomarkers Revenue by Regions (2015-2020) (USD Million)
Table 119. South America Neurological Biomarkers Sales by Countries (2015-2020) (K Units)
Table 120. South America Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table 121. South America Neurological Biomarkers Revenue by Countries (2015-2020) (USD Million)
Table 122. South America Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Table 123. Middle East & Africa Neurological Biomarkers Sales by Countries (2015-2020) (K Units)
Table 124. Middle East & Africa Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Table 125. Middle East & Africa Neurological Biomarkers Revenue by Countries (2015-2020) (USD Million)
Table 126. Middle East & Africa Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Table 127. Global Neurological Biomarkers Sales by Type (2015-2020) (K Units)
Table 128. Global Neurological Biomarkers Sales Share by Type (2015-2020)
Table 129. Global Neurological Biomarkers Revenue by Type (2015-2020) (USD Million)
Table 130. Global Neurological Biomarkers Revenue Share by Type (2015-2020)
Table 131. Global Neurological Biomarkers Sales by Application (2015-2020) (K Units)
Table 132. Global Neurological Biomarkers Sales Share by Application (2015-2020)
Table 133. Global Neurological Biomarkers Sales Forecast by Regions (2021-2025) (K Units)
Table 134. Global Neurological Biomarkers Market Share Forecast by Regions (2021-2025)
Table 135. Global Neurological Biomarkers Sales Forecast by Type (2021-2025) (K Units)
Table 136. Global Neurological Biomarkers Market Share Forecast by Type (2021-2025)
Table 137. Global Neurological Biomarkers Sales Forecast by Application (2021-2025)
Table 138. Global Neurological Biomarkers Market Share Forecast by Application (2021-2025)
Table 139. Direct Channel Pros & Cons
Table 140. Indirect Channel Pros & Cons
Table 141. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neurological Biomarkers Picture
Figure 2. Global Sales Market Share of Neurological Biomarkers by Type in 2019
Figure 3. Proteomics Picture
Figure 4. Genomics Picture
Figure 5. Imaging Picture
Figure 6. Bioinformatics Picture
Figure 7. Others Picture
Figure 8. Neurological Biomarkers Sales Market Share by Application in 2019
Figure 9. Diagnostics Picture
Figure 10. Drug Discovery Picture
Figure 11. Personalized Medicine Picture
Figure 12. Others Picture
Figure 13. Global Neurological Biomarkers Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Neurological Biomarkers Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Neurological Biomarkers Sales Market Share by Manufacturer in 2019
Figure 34. Global Neurological Biomarkers Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Neurological Biomarkers Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Neurological Biomarkers Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Neurological Biomarkers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Neurological Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 41. Global Neurological Biomarkers Revenue Market Share by Regions in 2018
Figure 42. North America Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure 43. Europe Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure 45. South America Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Neurological Biomarkers Sales and Growth Rate (2015-2020)
Figure 47. North America Neurological Biomarkers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Neurological Biomarkers Sales Market Share by Countries (2015-2020)
Figure 49. North America Neurological Biomarkers Sales Market Share by Countries in 2018
Figure 50. North America Neurological Biomarkers Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Neurological Biomarkers Revenue Market Share by Countries in 2018
Figure 52. United States Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Neurological Biomarkers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Neurological Biomarkers Revenue Market Share by Countries in 2019
Figure 58. Germany Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Neurological Biomarkers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Neurological Biomarkers Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Neurological Biomarkers Revenue Market Share by Regions 2019
Figure 66. China Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Neurological Biomarkers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Neurological Biomarkers Sales Market Share by Countries in 2019
Figure 73. South America Neurological Biomarkers Revenue Market Share by Countries in 2019
Figure 74. Brazil Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Neurological Biomarkers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Neurological Biomarkers Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Neurological Biomarkers Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Neurological Biomarkers Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Neurological Biomarkers Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Neurological Biomarkers Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Neurological Biomarkers Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Neurological Biomarkers Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Neurological Biomarkers Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Neurological Biomarkers Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
ゲノミクスバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…- 糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…
- 予測バイオマーカーの世界市場（～2026年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…
- バイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 希少神経疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Rare Neurological Disease Treatment Market The global Rare Neurological Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rare Neurological Disease Treatment Scope a…